Idogen AB (Sweden) Price on October 18, 2024
IDOGEN Stock | SEK 0.12 0.00 0.00% |
If you're considering investing in Idogen Stock, it is important to understand the factors that can impact its price. As of today, the current price of Idogen AB stands at 0.12, as last reported on the 30th of November, with the highest price reaching 0.12 and the lowest price hitting 0.12 during the day. We have found three technical indicators for Idogen AB, which you can use to evaluate the volatility of the firm.
Idogen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Idogen |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
IDOGEN |
Based on monthly moving average Idogen AB is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Idogen AB by adding Idogen AB to a well-diversified portfolio.
Idogen AB Valuation on October 18, 2024
It is possible to determine the worth of Idogen AB on a given historical date. On October 18, 2024 Idogen was worth 0.12 at the beginning of the trading date compared to the closed value of 0.12. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Idogen AB stock. Still, in general, we apply an absolute valuation method to find Idogen AB's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Idogen AB where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Idogen AB's related companies.
Open | High | Low | Close | Volume | |
0.12 | 0.12 | 0.12 | 0.12 | 1.00 | |
10/18/2024 | 0.12 | 0.12 | 0.12 | 0.12 | 1.00 |
0.12 | 0.12 | 0.12 | 0.12 | 1.00 |
Backtest Idogen AB | | | Idogen AB History | | | Idogen AB Valuation | Previous | Next |
Idogen AB Trading Date Momentum on October 18, 2024
On October 21 2024 Idogen AB was traded for 0.12 at the closing time. The highest price during the trading period was 0.12 and the lowest recorded bid was listed for 0.12 . There was no trading activity during the period 1.0. Lack of trading volume on October 21, 2024 did not cause price change. The trading delta at closing time to the current price is 0.00% . |
Idogen AB Fundamentals Correlations and Trends
By evaluating Idogen AB's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Idogen AB's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Idogen financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Idogen AB Stock history
Idogen AB investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Idogen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Idogen AB will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Idogen AB stock prices may prove useful in developing a viable investing in Idogen AB
Idogen AB Stock Technical Analysis
Idogen AB technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Idogen AB Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Idogen AB cannot be verified against its exchange. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Idogen AB November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Idogen AB stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Idogen AB shares will generate the highest return on investment. By undertsting and applying Idogen AB stock market strength indicators, traders can identify Idogen AB entry and exit signals to maximize returns
Complementary Tools for Idogen Stock analysis
When running Idogen AB's price analysis, check to measure Idogen AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Idogen AB is operating at the current time. Most of Idogen AB's value examination focuses on studying past and present price action to predict the probability of Idogen AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Idogen AB's price. Additionally, you may evaluate how the addition of Idogen AB to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |